Published by Josh White on 10th June 2022
(Sharecast News) - Renalytix updated the market on the deployment of its 'KidneyIntelX' bioprognostic testing in 1,112 adult diabetic kidney disease (DKD) patients at Mount Sinai Health System on Friday.
URL: http://www.digitallook.com/dl/news/story/32740918/...